Clinical Trial Update: Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating biomarkers related to Beta-catenin activation in non-resectable hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Queen's Medical Center | Conditions: Hepatocellular Carcinoma Non-resectable | Phase 2 | Status: RECRUITING